share_log

Breaking Down Bicycle Therapeutics: 8 Analysts Share Their Views

Breaking Down Bicycle Therapeutics: 8 Analysts Share Their Views

解析Bicycle Therapeutics:8位分析师分享他们的看法
Benzinga ·  12/17 02:00

In the last three months, 8 analysts have published ratings on Bicycle Therapeutics (NASDAQ:BCYC), offering a diverse range of perspectives from bullish to bearish.

The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings51200
Last 30D10000
1M Ago00100
2M Ago41100
3M Ago00000

The 12-month price targets, analyzed by analysts, offer insights with an average target of $37.0, a high estimate of $55.00, and a low estimate of $17.00. Observing a downward trend, the current average is 14.81% lower than the prior average price target of $43.43.

bigjpg

Interpreting Analyst Ratings: A Closer Look

The perception of Bicycle Therapeutics...

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发